CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new vaccine carriers using inorganic nanoparticles to enhance immunogenicity while minimizing side effects. It focuses on characterizing these carriers through advanced NMR spectroscopy to improve vaccine safety and efficacy.
There is an urgent need for new vaccines, but avoiding side effects is crucial for patient compliance.
To address this, new generation vaccines with safe, but weakly immunogenic antigens are formulated with carriers and adjuvants to induce the desired immunological response.
Inorganic nanoparticles (NP) have shown potential as carriers while immune stimulators of microbial origin are proven to ensure long lasting immune response.
Their successful integration into nanovaccines requires thorough a…
UNIVERSITEIT GENT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
